bioRxivBiophysics
The Landscape of Mutations in Fumarate Hydratase
Abstract
Fumarate Hydratase (FH) is an enzyme of the citric acid (TCA) cycle that is responsible for reversibly catalysing the conversion between fumarate and malate. FH loss and subsequent buildup of the oncometabolite fumarate causes hereditary leiomyomatosis and renal cell carcinoma. We explore the mutational landscape of FH in silico, predict the functional effects of many already detected mutations, and categorise detected but un-characterised mutations in human populations. Using mutational energy predicting tools such as Rosetta and FoldX we accurately predict mutations and mutational hotspots with high disruptive capability. Furthermore, through performing molecular dynamics simulations we show that hinge regions of the protein can be stabilized or destabilized by mutations, with new mechanistic implications of the consequences on the binding affinity of the enzyme for its substrates. Finally, we categorise all potential mutations in FH into functional groups, and predict which known mutations in the human population are loss-of-function, and therefore predispose patients to papillary renal carcinoma - we validate our findings through analysis of metabolomics data of characterized cell lines.
- organism: human
- assay: proteomics
- research focus: variant effect prediction
- approach: statistical model
- approach: deep learning
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of activators of human fumarate hydratase by quantitative high-throughput screening
H. Zhu, O. W. Lee, … M. D. Hall·bioRxiv·Jul 2, 2019
- Revisiting the burden borne by fumarase: enzymatic hydration of an olefin
A. Bellur, S. Das, … H. Balaram·bioRxiv·Sep 3, 2022
- HIRA loss transforms FH-deficient cells
L. Valcarcel-Jimenez, C. Rogerson, … C. Frezza·bioRxiv·Jun 4, 2022
- Depletion of FH, an essential TCA cycle enzyme, drives proliferation in a two-step model
B. Solaimuthu, M. Lichtenstein, … Y. D. Shaul·bioRxiv·Jun 16, 2022
- FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer
B. R. Wilde, N. Chakraborty, … H. R. Christofk·bioRxiv·Aug 15, 2022
- A chemoproteomic portrait of the oncometabolite fumarate
R. A. Kulkarni, D. W. Bak, … J. L. Meier·bioRxiv·Mar 22, 2018